Denali Therapeutics Inc.

DNLI · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $3.2B · 503 employees
147
SEC Filings
$20.41
Close 2026-06-01
503
Employees

Business Summary

Overview and Strategy Our purpose is to bring the power of biotherapeutics to the whole body, including the brain, by discovering, developing, and delivering medicines for people living with serious diseases. Historically, the blood-brain barrier has been a major challenge to the development of medicines for diseases of the central nervous system. While the blood-brain barrier protects the brain and is essential for our survival, it also prevents the delivery of medicines to the brain in suffici...

Latest Stock Quote

DNLI 2026-06-01 $20.41 O:$20.73 H:$20.865 L:$20.03 Vol:1.7M VWAP:$20.4365
origin leaf: f173d4ffa4b34d0c0847abd24bd1af40b5241eb30f1e73c550df5d133e734515

Next Earnings

Q2 FY2026 — expected 2026-08-08

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001714899-26-000021EDGAR96K words
2025-02-272024-12-310001714899-25-000066EDGAR—
2024-02-282023-12-310001714899-24-000086EDGAR—
2023-02-272022-12-310001714899-23-000049EDGAR—
2022-02-282021-12-310001714899-22-000058EDGAR—
2021-02-262020-12-310001714899-21-000033EDGAR—
2020-02-272019-12-310001714899-20-000026EDGAR—
2019-03-122018-12-310001714899-19-000015EDGAR—
2018-03-192017-12-310001193125-18-086723EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001714899-25-000193EDGAR53K words
2025-08-112025-06-300001714899-25-000170EDGAR—
2025-05-062025-03-310001714899-25-000105EDGAR—
2024-11-062024-09-300001714899-24-000216EDGAR—
2024-08-012024-06-300001714899-24-000169EDGAR—
2024-05-072024-03-310001714899-24-000121EDGAR—
2023-11-072023-09-300001714899-23-000146EDGAR—
2023-08-082023-06-300001714899-23-000120EDGAR—
2023-05-082023-03-310001714899-23-000075EDGAR—
2022-11-032022-09-300001714899-22-000144EDGAR—
2022-08-082022-06-300001714899-22-000123EDGAR—
2022-05-052022-03-310001714899-22-000078EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001714899-26-000042EDGAR1K words
2026-03-310001714899-26-000036EDGAR—
2026-03-250001714899-26-000030EDGAR—
2026-02-260001714899-26-000020EDGAR—
2026-01-060001714899-26-000004EDGAR—
2025-12-100001628280-25-056363EDGAR—
2025-12-040001714899-25-000209EDGAR—
2025-12-040001714899-25-000208EDGAR—
2025-11-060001714899-25-000192EDGAR—
2025-10-140001714899-25-000180EDGAR—

147 total filings indexed. 116 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001714899
TickerDNLI
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.denalitherapeutics.com
Listed2017-12-08

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7fefa841ba5bbc27f5466dda66fd01187921d604466cbb45111094d2f04a5a06
parent: 4b7f33d548d38b47c49d33bf7bffbf7d6630d2ee9f5a3220a7b409083ea567ef
content hash: c65c32d53f7e0972876187dc09037e889e7751a67c5746b9a70421cd24c8fa44
signed: 2026-06-02T19:00:53.458Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf